Search Orphan Drug Designations and Approvals
-
Generic Name: | N-methyl-4-({4-[({3-methyl(methylsulfonyl)amino]pyrazin-2-yl}methyl)amino]-5-(trifluoromethyl)pyrimidin-2-yl}amino)benzamide hydrochloride |
---|---|
Date Designated: | 07/18/2013 |
Orphan Designation: | Treatment of mesothelioma |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 09/15/2023 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Verastem, Inc. 117 Kendrick Street Suite 500 Needham, Massachusetts 02494 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-